(Q43422461)

English

Quantitative real-time polymerase chain reaction for monitoring minimal residual disease in patients with advanced indolent lymphomas treated with rituximab, fludarabine, mitoxantrone, and dexamethasone

scientific article published in February 2002

Statements

Quantitative real-time polymerase chain reaction for monitoring minimal residual disease in patients with advanced indolent lymphomas treated with rituximab, fludarabine, mitoxantrone, and dexamethasone (English)
0 references
Andreas H Sarris
Yunfang Jiang
Athanasios Thomaides
George Z Rassidakis
Richard J Ford
L Jeffrey Medeiros
Fernando Cabanillas
Peter McLaughlin
1 February 2002
1 Suppl 2
48-55

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit